
<!-- saved from url=(0063)file:///C:/Users/ygowda/Desktop/output/18646816/18646816_8.html -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"></head><body><table border="1">
<tbody><tr><td>
<p></p></td><td>
<p></p></td><td colspan="3" style="vertical-align:middle;">
<p><span class="font0">Quarter Ended</span></p></td><td colspan="2" style="vertical-align:middle;">
<p><span class="font0">Year Ended</span></p></td></tr>
<tr><td rowspan="2" style="vertical-align:middle;">
<p><span class="font0">Sr. No.</span></p></td><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">31 March</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">31 December</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">31 March</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">31 March</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">31 March</span></p></td></tr>
<tr><td>
<p><span class="font0">Particulars</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">(Audited)</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">(Unaudited)</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">(Audited)</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">(Audited)</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">(Audited)</span></p></td></tr>
<tr><td>
<p></p></td><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">2018</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">2017</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">2017</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">2018</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">2017</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0">1</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">Segment revenue</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">a. Pharmaceuticals</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">123774</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">110073</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">80847</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">401679</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">311665</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">b. Life Sciences Ingredients</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">96981</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">92574</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">78384</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">337239</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">271432</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">c. Drug Discovery Solutions</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">4694</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">4485</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">5130</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">17723</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">18241</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Total</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">225449</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">207132</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">164361</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">756641</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">601338</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Less : Intersegment revenue</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">253</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">356</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">219</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">860</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">706</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Total revenue from operations</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">225196</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">206776</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">164142</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">755781</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">600632</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">a. Pharmaceuticals</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">123774</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">110073</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">80847</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">401661</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">311665</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">b. Life Sciences Ingredients</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">96751</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">92245</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">78196</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">336489</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">270762</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">c. Drug Discovery Solutions</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">4671</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">4458</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">5099</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">17631</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">18205</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Total</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">225196</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">206776</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">164142</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">755781</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">600632</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0">2</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">Segment results (proflt(+)/loss(-) before tax, exceptional Items and Interest from each segment)</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">a. Pharmaceuticals</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">14155</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">17701</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">16566</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">66164</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">78536</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">b. Life Sciences Ingredients</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">16589</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">18505</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">9573</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">54814</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">35170</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">â–  Drue Discovery Solutions</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">795</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">65</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">236</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">806</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">1263</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Total</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">31539</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">36271</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">26375</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">121784</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">114969</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">Less : i Interest (Finance costs)</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">7248</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">7706</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">8019</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">28428</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">34111</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">ii Exceptional items and un-allocable expenditure (net of un-allocable income)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">1635</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">2447</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">2346</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">7448</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">7094</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Profit before tax</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">22656</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">26118</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">16010</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">85908</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">73764</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font0">3</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">Segment assets</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">a. Pharmaceuticals</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">617084</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">607962</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">586963</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">617084</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">586963</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">b. Life Sciences Ingredients</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">293088</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">290172</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">260353</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">293088</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">260353</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">c. Drug Discovery Solutions</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">15938</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">17844</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">18007</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">15938</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">18007</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">d Unallocable corDorate assets (excluding deferred tax assets)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">19607</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">20758</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">24552</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">19607</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">24552</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Total Segment assets</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">945717</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">936736</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">889875</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">945717</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">889875</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font0">4</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">Segment liabilities</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">a. Pharmaceuticals</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">63034</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">58960</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">44878</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">63034</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">44878</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">b. Life Sciences Ingredients</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">86811</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">77608</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">60289</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">86811</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">60289</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">c. Drug Discovery Solutions</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">3372</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">3341</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">3018</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">3372</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">3018</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">d Unallocable corporate liabilities (excluding borrowings and deferred tax liabilities)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">41849</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">36322</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">33846</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">41849</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">33846</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Total Segment liabilities</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">195066</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">176231</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">142031</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">195066</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">142031</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font0">5</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">Capital employed (Segment assets less Segment liabilities)</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">a. Pharmaceuticals</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">554050</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">549002</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">542085</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">554050</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">542085</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">b. Life Sciences Ingredients</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">206277</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">212564</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">200064</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">206277</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">200064</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">c Drug Discovery Solutions</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">12566</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">14503</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">14989</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">12566</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">14989</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font0">d. Unallocable corporate assets less liabilities</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">(22242)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">(15564)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">(9294)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">(22242)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">(9294)</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:middle;">
<p><span class="font0">Total Capital employed</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">750651</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">760505</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">747844</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">750651</span></p></td><td style="vertical-align:middle;">
<p><span class="font0">747844</span></p></td></tr>
</tbody></table></body></html>